Home > Insider Trading > Filing (0000899243-20-022644)

Filing Details

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1060736	Seattle Genetics Inc	SGEN	Biological Products, (No Disgnostic Substances) (2836)	911874389

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1741836	D Roger Dansey	21823 30Th Drive Se Bothell WA 98021	Chief Medical Officer	No	Yes	No	No

Reported Non-Derivative Transactions

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Common Stock	Acquisiton	2020-08-17	13,192	$0.00	122,943	No	4	A	Direct
Common Stock	Disposition	2020-08-17	450	$157.79	122,493	No	4	S	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	A	Direct
No	4	S	Direct

Reported Derivative Transactions

Sec. Name	Sec. Type	Acquisiton - Disposition	Date	Amount	Price	Amount - 2	Price - 2
Common Stock	Incentive Stock Option (right to buy)	Acquisiton	2020-08-17	636	$0.00	636	$161.82
Common Stock	Non-Qualified Stock Option (right to buy)	Acquisiton	2020-08-17	32,073	$0.00	32,073	$161.82

Remaning Holdings	Exercise Date	Expiration Date	Equity Swap Involved	Transaction Form Type	Transaction Code	Nature of Ownership
636		2030-08-17	No	4	A	Direct
32,073		2030-08-17	No	4	A	Direct

Footnotes

These shares represent restricted stock units and will be settled in common stock upon vesting.
Shares shall vest at a rate of 25% on each anniversary of August 15, 2020 until all shares are fully vested at the end of four years.
Amount of securities beneficially owned following reported transactions includes restricted stock units subject to vesting and 143 shares acquired under the Amended and Restated 2000 Employee Stock Purchase Plan on 7/31/2020.
The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan.
Options shall vest at a rate of 25% one year from grant date and monthly thereafter until all shares are fully vested four years from grant date.